Table 3.

Organic, inorganic, and carbon-containing nanomaterials for targeted medicinal uses [84].

Nanomaterials	Antibiotics/Drugs	Target Bacteria/Diseases	References
Ag NPs	Ciprofloxacin, vancomycin Clotrimazole	VRE, MRSA MRSA, S. aureus,	[38,39]
Au NPs	Vancomycin, ampicillin	MRSA, MRSA, P. aeruginosa, Enterobacter aerogenes, E. coli	[42]
ZnO NPs	Ciprofloxacin, ceftazidime	MDRA. baumannii	[49]
Fe3O4 NPs	Ampicillin Ampicillin	S. aureus E. coli, P. aeruginosa, MRSA
SWCNTs	Ciprofloxacin	S. aureus, P. aeruginosa, E. coli	[84,85]
Chitosan	Streptomycin Ciprofloxacin	Listeria monocytogenes Uropathogenic E. coli	[62]
Liposome	Pioglitazone (PIO), dexamethasone plus minocycline	Atherosclerotic plaques Orthopedic/dental implants	[59]
Exosome	Curcumin	Septic shock	[68]